先证者
无义突变
阿尔波特综合征
遗传学
复合杂合度
突变
外显子组
外显子组测序
杂合子优势
基因
肾小球基底膜
生物
等位基因
错义突变
医学
肾小球肾炎
肾
作者
Cheng Yang,Yuan Song,Zhaowei Chen,Xinyi Yuan,Xinhua Chen,Guohua Ding,Yang Tai Guan,Mary McGrath,Chunhua Song,Yongqing Tong,Huiming Wang
标识
DOI:10.3389/fgene.2019.00628
摘要
Alport syndrome (AS) is a hereditary nephropathy characterized by glomerular basement membrane lesions. AS shows a relatively rare entity with autosomal dominant gene mutation (accounts for less than 5% of AS cases) and is widely believed to be a consequence of heterozygous variants in the COL4A3 and COL4A4 genes. Until now, there have been no reports of homozygous variants in genes in AS patients, and it is scarce to detect both homozygous and heterozygous variants in a single AS pedigree. We performed genetic analysis by exome sequencing (exome-seq) in a Chinese family with AS and found four individuals harboring the COL4A4 c.4599T > G variant, a novel COL4A4 nonsense mutation that gains stop codon and results in a truncated protein. The proband and her two siblings were determined to be heterozygous, whereas their mother was homozygous. The proband satisfied the criteria for the diagnosis of AS, which included clinical manifestations of microscopic hematuria and proteinuria, and pathological features of the glomerular basement membrane (GBM), including irregular thickening and splitting. However, the other three individuals who were homozygous or heterozygous for the variant exhibited mild clinical features with isolated microscopic hematuria. In summary, we identified a novel pathogenic variant in either the heterozygous or homozygous state of the COL4A4 gene in a Chinese family with AS. Our results also suggest that the severity of clinical manifestations may not be entirely attributed to by the COL4A4 genetic variant itself in patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI